References
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
- Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998;16:93–104
- Watanabe K, Mori T, Iwasaki A, et al. Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hypertens Res 2013;36:356–60
- Rani N, Dhingra R, Arya DS, et al. Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynaecol Res 2010;36:1189–94
- Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001;3:293–311
- Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990;37:57–84
- Grzebyk E, Piwowar A. Glycoxidative modification of albumin in medical research. Pol Merkur Lekarski 2013;34:239–42
- Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464–70
- Gafsou B, Lefèvre G, Hennache B, et al. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy 2010;29:101–11
- Hofman LF. Human saliva as a diagnostic specimen. J Nutr 2001;131:1621S–5S
- Bentur L, Mansour Y, Brik R, et al. Salivary oxidative stress in children during acute asthmatic attack and during remission. Respir Med 2006;100:1195–201
- Dodds MW, Yeh CK, Johnson DA. Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 2000;28:373–81
- Komatsu T, Duckyoung Y, Ito A, et al. Increased oxidative stress biomarkers in the saliva of Down syndrome patients. Arch Oral Biol 2013;58:1246–50
- Toker A, Aribas A, Yerlikaya FH, et al. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clin Lab Anal 2013;27:99–104
- ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 33, January 2002. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159–67
- Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 2000;19:311–15
- Varley RH, Gowenlock AH. Proteins. Pract Clin Biochem 1953;1:545–7
- Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013;3:4. doi: 10.1186/2110-5820-3-4
- Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes – review and clinical implications. Clin Chem Lab Med 2011;49:177–84
- Albarello K, dos Santos GA, Bochi GV, et al. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis. Clin Biochem 2012;45:450–4
- Wu AH, Morris DL, Fletcher DR, et al. Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001;1:147–51
- Guven S, Alver A, Mentese A, et al. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009;88:479–82
- Papageorghiou AT, Prefumo F, Leslie K, et al. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod 2008;23:803–6
- Ustün Y, Engin-Ustün Y, Oztürk O, et al. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011;24:418–21
- Sinha MK, Vazquez JM, Calvino R, et al. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 2006;92:1852–3
- Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006;39:143–51
- Holt JL, Mangos GJ, Brown MA. Measuring protein excretion in pregnancy. Nephrology (Carlton) 2007;12:425–30
- Canakci V, Yildirim A, Canakci CF, et al. Total antioxidant capacity and antioxidant enzymes in serum, saliva, and gingival cervicular fluid of preeclamptic women with and without periodontal disease. J Periodontol 2007;78:1602–11
- Van Rijn BB, Franx A, Sikkema JM, et al. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:159–67
- Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006;45:189–200
- Fujimaki A, Watanabe K, Mori T, et al. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta 2011;32:367–72
- Gugliucci A, Hermo R, Monroy C, et al. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–60